NOOSPHERE

Fichas públicas de documentos

Referencias bibliográficas de procedencia pública y con enlaces estables. El catálogo no incluye todos los documentos del corpus ni reproduce sus textos completos.

98,186 fichas públicas · página 306 / 982

  1. Book Symposium: Philosophy of Psychedelics2022 · Crossref
  2. Botanical Ecstasies: Psychoactive Plant Formulas in India and Beyond, by Matthew Clark.2022 · OpenAlex
  3. Brain 5-HT2A receptor binding and its neural network related to behavioral inhibition system2022 · OpenAlex
  4. Brain and spinal cord trauma: what we know about the therapeutic potential of insulin growth factor 1 gene therapy2022 · Crossref
  5. Brain Changes Associated With Long-Term Ketamine Abuse, A Systematic Review2022 · OpenAlex
  6. Brain Network Allostasis after Chronic Alcohol Drinking Is Characterized by Functional Dedifferentiation and Narrowing2022 · Crossref
  7. Brain network dysfunctions in addiction: a meta-analysis of resting-state functional connectivity2022 · OpenAlex
  8. Brain networks alterations in cocaine use and gambling disorders during emotion regulation2022 · OpenAlex
  9. Brain structural covariance network differences in adults with alcohol dependence and heavy‐drinking adolescents2022 · Crossref
  10. Brain systems in cocaine abstinence-induced anxiety-like behavior in rodents: A review2022 · OpenAlex
  11. Brain-derived neurotrophic factor protects serotonergic neurons against 3,4-methylenedioxymethamphetamine (“Ecstasy”) induced cytoskeletal damage2022 · OpenAlex
  12. BRANCH RETINAL ARTERY OCCLUSION WITH PARACENTRAL ACUTE MIDDLE MACULOPATHY PRESUMABLY RELATED TO HEAVY CANNABIS USE2022 · Crossref
  13. Branding Phenomenon of Local Coffee in Shifting the Existence of Foreign Coffee Brands in Jakarta, Indonesia2022 · Crossref
  14. Brasil y el Narcoanálisis2022 · OpenAlex
  15. Brazilian Psychiatric Association Consensus for the Management of Acute Intoxication: general management and specific interventions for drugs of abuse2022 · OpenAlex
  16. Breaking the Connection Between Depressive Symptoms and Alcohol Use Among Adolescents With a Text-Message Delivered Intervention: A Randomized Controlled Pilot Trial in Primary Care2022 · Crossref
  17. Bridge clinic implementation of “72-hour rule” methadone for opioid withdrawal management: Impact on opioid treatment program linkage and retention in care2022 · OpenAlex
  18. Bridge Nodes between Personality Traits and Alcohol-Use Disorder Criteria: The Relevance of Externalizing Traits of Risk Taking, Callousness, and Irresponsibility2022 · Crossref
  19. Bridging: Accelerating Regulatory Acceptance of Reduced-Risk Tobacco and Nicotine Products2022 · Crossref
  20. Brief Maternal Separation Inoculates Against the Effects of Social Stress on Depression-Like Behavior and Cocaine Reward in Mice2022 · OpenAlex
  21. Brief motivational intervention extends antidepressant effect of ketamine2022 · Crossref
  22. Brief Report: Higher Fentanyl Exposures Require Higher Doses of Naloxone for Successful Reversals in a Quantitative Systems Pharmacology Model2022 · Crossref
  23. Broad coalition calls for increasing addiction workforce2022 · Crossref
  24. Broad-spectrum cannabis oil ameliorates reserpine-induced fibromyalgia model in mice2022 · OpenAlex
  25. Broadband access and telemedicine adoption for opioid use disorder treatment in the United States2022 · Crossref
  26. Broken Windows, Naloxone, and Experiments in Policing2022 · Crossref
  27. Brugada syndrome: should we be screening patients before prescribing psychotropic medication?2022 · Crossref
  28. Buckwheat and Amaranth as Raw Materials for Brewing, a Review2022 · Crossref
  29. Buckypaper-Based Nanostructured Sensor for Port Wine Analysis2022 · OpenAlex
  30. Buddhist-like opposite diminishing and non-judging during ketamine infusion are associated with antidepressant response: an open-label personalized-dosing study2022 · OpenAlex
  31. Building a case for trust: reputation, institutional regulation and social ties in online drug markets2022 · OpenAlex
  32. Building engagement to support adoption of community-based substance use prevention initiatives2022 · OpenAlex
  33. Buprenorphine and naloxone access in pharmacies within high overdose areas of Los Angeles during the COVID-19 pandemic2022 · Crossref
  34. Buprenorphine as a Treatment for Major Depression and Opioid Use Disorder2022 · Crossref
  35. Buprenorphine exposure levels to optimize treatment outcomes in opioid use disorder2022 · Crossref
  36. Buprenorphine implementation at syringe service programs following waiver of the Ryan Haight Act in the United States2022 · OpenAlex
  37. Buprenorphine initiation strategies for opioid use disorder and pain management: A systematic review2022 · OpenAlex
  38. Buprenorphine Use Trends Following Removal of Prior Authorization Policies for the Treatment of Opioid Use Disorder in 2 State Medicaid Programs2022 · OpenAlex
  39. Buprenorphine versus Methadone for Opioid Use Disorder in Pregnancy2022 · OpenAlex
  40. Buprenorphine-naloxone Versus Buprenorphine for Treatment of Opioid Use Disorder in Pregnancy2022 · Crossref
  41. Buprenorphine/naloxone (Suboxone®) withdrawal may facilitate antipsychotic-induced priapism. A case report2022 · Crossref
  42. Buprenorphine/naloxone access for people with opioid use disorder in correctional facilities: taking steps to support knowledge translation2022 · OpenAlex
  43. Business activity in substance use remains strong with diverse funding2022 · Crossref
  44. Business Feasibility Study Analysis on Coffee Shop Business2022 · Crossref
  45. Business Model Strategies to Built A Sustainable Economy for Agrotourism at Coffee Farming in Kopi Warga Study Case: TerminalBusiness Model Strategies to Built A Sustainable Economy for Agrotourism at Coffee Farming in Kopi Warga Study Case: Terminal2022 · Crossref
  46. Business Process Reengineering pada Coffee Shop Coffee Secret’s Menggunakan Aplikasi Dolibarr2022 · Crossref
  47. C. elegans as a test system to study relevant compounds that contribute to the specific health-related effects of different cannabis varieties2022 · Crossref
  48. Cadmium and Lead Concentration in Drinking Instant Coffee, Instant Coffee Drinks and Coffee Substitutes: Safety and Health Risk Assessment2022 · Crossref
  49. Caffeic Acid and Diseases—Mechanisms of Action2022 · OpenAlex
  50. Caffeine and attentional control: improved and impaired performance in healthy older adults and Parkinson’s disease according to task demands2022 · Crossref
  51. Caffeine and Its Antioxidant Properties—It Is All about Dose and Source2022 · OpenAlex
  52. Caffeine and MDMA (Ecstasy) Exacerbate ER Stress Triggered by Hyperthermia2022 · OpenAlex
  53. Caffeine Content of Bondowoso Arabica Ground Coffee with Variation of Roasting Profile and Type of Packages2022 · Crossref
  54. Caffeine Intake among Undergraduate Students: Sex Differences, Sources, Motivations, and Associations with Smoking Status and Self-Reported Sleep Quality2022 · OpenAlex
  55. California cannabis cultivation and processing workers: A qualitative analysis of physiological exposures and health effects2022 · Crossref
  56. Calling time on responsible drinking: A qualitative study of perceptions of information on alcohol product labels2022 · Crossref
  57. Calm Down With Kava: What Clinicians Need to Know2022 · Crossref
  58. Campus administrator perceptions of the effectiveness of tobacco-free policies in California universities2022 · Crossref
  59. Can alternative nicotine products put the final nail in the smoking coffin?2022 · Crossref
  60. Can cannabis kill? Characteristics of deaths following cannabis use in England (1998–2020)2022 · Crossref
  61. Can chatbots help to motivate smoking cessation? A study on the effectiveness of motivational interviewing on engagement and therapeutic alliance2022 · OpenAlex
  62. Can Mesoporous Silica Speed Up Degradation of Benzodiazepines? Hints from Quantum Mechanical Investigations2022 · Crossref
  63. Can PATH Study susceptibility measures predict e‐cigarette and cigarette use among American youth 1 year later?2022 · Crossref
  64. Can Prescribed Cannabinoids Substitute Cannabis?2022 · Crossref
  65. Can psilocybin be safely administered under medical supervision? A systematic review of adverse event reporting in clinical trials2022 · Crossref
  66. Can psychedelic-assisted psychotherapy play a role in enhancing motivation to change in addiction treatment settings?2022 · Crossref
  67. Can States Continue to Set the Agenda for Tobacco 21? Insights From US News Coverage Between 2012 and 20202022 · Crossref
  68. Can substance abuse media literacy increase prediction of drug use in students?2022 · Crossref
  69. Can synthetic cannabinoids be reliably screened with electrochemistry? An assessment of the ability to screen for synthetic cannabinoids STS-135 and BB-22 within a single sample matrix2022 · OpenAlex
  70. Can the revival of serotonergic psychedelic drugs as treatments for mental disorders help to characterize their risks and benefits?2022 · OpenAlex
  71. Can the use of long-acting injectable antipsychotic preparations be increased in routine clinical practice and the benefits realised?2022 · Crossref
  72. Canadian adolescents’ mental health and substance use during the COVID-19 pandemic: Associations with COVID-19 stressors.2022 · OpenAlex
  73. Canadian Resources on Cannabis Use and Fertility, Pregnancy, and Lactation: Scoping Review2022 · Crossref
  74. Cancer causing chewing habits and related oral lesions – A comparative study among females of socio-culturally different areas of West Bengal2022 · Crossref
  75. Cancer Pain and Opioid Use Disorder2022 · OpenAlex
  76. Cancer Pain and Therapy2022 · OpenAlex
  77. Cancer-associated fibroblast-specific lncRNA LINC01614 enhances glutamine uptake in lung adenocarcinoma2022 · OpenAlex
  78. Cannabidiol (CBD) Dosing: Plasma Pharmacokinetics and Effects on Accumulation in Skeletal Muscle, Liver and Adipose Tissue2022 · OpenAlex
  79. Cannabidiol (CBD) for relief from pain, anxiety, and epilepsy: A review2022 · OpenAlex
  80. Cannabidiol (CBD) in Cancer Management2022 · OpenAlex
  81. Cannabidiol (CBD) in the Self-Treatment of Depression-Exploratory Study and a New Phenomenon of Concern for Psychiatrists2022 · OpenAlex
  82. Cannabidiol and Cannabidiol Metabolites: Pharmacokinetics, Interaction with Food, and Influence on Liver Function2022 · OpenAlex
  83. Cannabidiol and Cannabigerol Inhibit Cholangiocarcinoma Growth In Vitro via Divergent Cell Death Pathways2022 · OpenAlex
  84. Cannabidiol and Other Phytocannabinoids as Cancer Therapeutics2022 · OpenAlex
  85. Cannabidiol as a treatment for arthritis and joint pain: an exploratory cross-sectional study2022 · Crossref
  86. Cannabidiol but not cannabidiolic acid reduces behavioural sensitisation to methamphetamine in rats, at pharmacologically effective doses2022 · OpenAlex
  87. Cannabidiol Does Not Impact Acute Anabolic or Inflammatory Signaling in Skeletal Muscle In Vitro2022 · Crossref
  88. Cannabidiol Enhances Microglial Beta-Amyloid Peptide Phagocytosis and Clearance via Vanilloid Family Type 2 Channel Activation2022 · OpenAlex
  89. Cannabidiol for neurodegenerative disorders: A comprehensive review2022 · OpenAlex
  90. Cannabidiol for the treatment of refractory epilepsy in children: a critical review of the literature2022 · OpenAlex
  91. Cannabidiol inhibits microglia activation and mitigates neuronal damage induced by kainate in an in-vitro seizure model2022 · OpenAlex
  92. Cannabidiol Inhibits Tumorigenesis in Cisplatin-Resistant Non-Small Cell Lung Cancer via TRPV22022 · OpenAlex
  93. Cannabidiol Interferes with Establishment of Δ 9 -Tetrahydrocannabinol-Induced Nausea Through a 5-HT 1A Mechanism2022 · Crossref
  94. Cannabidiol Reduced the Severity of Gastrointestinal Symptoms of Opioid Withdrawal in Male and Female Mice2022 · Crossref
  95. Cannabidiol, the Journey of Cannabis from a Social Stigma to a Miracle Drug in Dentistry2022 · Crossref
  96. Cannabidiol‐rich non‐psychotropic Cannabis sativa L. oils attenuate peripheral neuropathy symptoms by regulation of CB2‐mediated microglial neuroinflammation2022 · Crossref
  97. Cannabinoid CB2 Receptors in Neurodegenerative Proteinopathies: New Insights and Therapeutic Potential2022 · OpenAlex
  98. Cannabinoid CB2 Receptors Modulate Microglia Function and Amyloid Dynamics in a Mouse Model of Alzheimer’s Disease2022 · OpenAlex
  99. Cannabinoid Conference 20222022 · OpenAlex
  100. Cannabinoid Content and Label Accuracy of Hemp-Derived Topical Products Available Online and at National Retail Stores2022 · OpenAlex